Susan Horvath
Net Worth

Last updated:

What is Susan Horvath net worth?

The estimated net worth of Ms. Susan Horvath is at least $2,213,403 as of 30 Jan 2023. She owns shares worth $1,403 as insider and has received compensation worth at least $2,212,000 in Panbela Therapeutics, Inc..

What is the salary of Susan Horvath?

Ms. Susan Horvath salary is $316,000 per year as Vice President of Fin., Chief Financial Officer, Sec. & Treasurer in Panbela Therapeutics, Inc..

How old is Susan Horvath?

Ms. Susan Horvath is 66 years old, born in 1959.

What stocks does Susan Horvath currently own?

As insider, Ms. Susan Horvath owns shares in one company:

Company Title Shares Price per share Total value
Panbela Therapeutics, Inc. (PBLA) Vice President of Fin., Chief Financial Officer, Sec. & Treasurer 8,888 $0.16 $1,403

What does Panbela Therapeutics, Inc. do?

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.

PBLA logo
PBLA
Panbela Therapeutics, Inc.
$0.16

Susan Horvath insider trading

Panbela Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Warrants (right to buy) 8,888 $2.75 $24,442
Purchase
Common Stock 4,444 N/A N/A
Purchase
Warrant (right to buy) 4,848 $4.54 $22,010
Purchase
Common Stock 2,500 $6 $15,000
Purchase
Warrant (right to buy) 2,500 $6 $15,000
Purchase
Common Stock 1,428 $4 $5,712
Purchase
Warrant (right to buy) 1,428 $4 $5,712
Purchase
Warrant (right to buy) 13,500 N/A N/A
Purchase
Convertible Promissory Note 23,625 $3.5 $82,688

Panbela Therapeutics key executives

Panbela Therapeutics, Inc. executives and other stock owners filed with the SEC:

  • Dr. Jennifer K. Simpson C.R.N.P., CRNP, M.S.N., Ph.D. (57) Chief Executive Officer, Pres & Director
  • Ms. Susan Horvath (66) Vice President of Fin., Chief Financial Officer, Sec. & Treasurer